Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Nagane M, Ichimura K, Onuki R, Narushima D, Honda-Kitahara M, Satomi K, Tomiyama A, Arai Y, Shibata T, Narita Y, Uzuka T, Nakamura H, Nakada M, Arakawa Y, Ohnishi T, Mukasa A, Tanaka S, Wakabayashi T, Aoki T, Aoki S, Shibui S, Matsutani M, Ishizawa K, Yokoo H, Suzuki H, Morita S, Kato M, Nishikawa R. Nagane M, et al. Among authors: ohnishi t. Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522. Cancers (Basel). 2022. PMID: 36428615 Free PMC article.
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma.
Nishikawa M, Inoue A, Ohnishi T, Yano H, Kanemura Y, Kohno S, Ohue S, Ozaki S, Matsumoto S, Suehiro S, Nakamura Y, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Nishikawa M, et al. Among authors: ohnishi t. Cancer Med. 2021 Mar;10(6):2013-2025. doi: 10.1002/cam4.3767. Epub 2021 Feb 5. Cancer Med. 2021. PMID: 33543833 Free PMC article.
Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma.
Nishikawa M, Inoue A, Ohnishi T, Kohno S, Ohue S, Matsumoto S, Suehiro S, Yamashita D, Ozaki S, Watanabe H, Yano H, Takahashi H, Kitazawa R, Tanaka J, Kunieda T. Nishikawa M, et al. Among authors: ohnishi t. Stem Cells Int. 2018 Aug 23;2018:5387041. doi: 10.1155/2018/5387041. eCollection 2018. Stem Cells Int. 2018. PMID: 30210550 Free PMC article.
Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence.
Inoue A, Ohnishi T, Nishikawa M, Watanabe H, Kusakabe K, Taniwaki M, Yano H, Ohtsuka Y, Matsumoto S, Suehiro S, Yamashita D, Shigekawa S, Takahashi H, Kitazawa R, Tanaka J, Kunieda T. Inoue A, et al. Among authors: ohnishi t. Biomedicines. 2023 Aug 24;11(9):2369. doi: 10.3390/biomedicines11092369. Biomedicines. 2023. PMID: 37760811 Free PMC article.
Oct-3/4 promotes migration and invasion of glioblastoma cells.
Kobayashi K, Takahashi H, Inoue A, Harada H, Toshimori S, Kobayashi Y, Goto K, Sugimoto K, Yano H, Ohnishi T, Tanaka J. Kobayashi K, et al. Among authors: ohnishi t. J Cell Biochem. 2012 Feb;113(2):508-17. doi: 10.1002/jcb.23374. J Cell Biochem. 2012. PMID: 21938739
1,882 results